DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Morgan Stanley Maintains Overweight on MyoKardia, Raises Price Target to $76

Morgan Stanley maintains MyoKardia (NASDAQ:MYOK) with a Overweight and raises the price target from $75 to $76.

Benzinga · 02/28/2020 13:27

Morgan Stanley maintains MyoKardia (NASDAQ:MYOK) with a Overweight and raises the price target from $75 to $76.